昂利康：化学原料药布比卡因上市申请获批准

Core Viewpoint - The company, Anglikang (002940.SZ), has received approval from the National Medical Products Administration for the marketing application of the chemical raw material drug, Bupivacaine, which is primarily used for local anesthesia and postoperative analgesia [1] Group 1 - The drug Bupivacaine is a chemical raw material approved for marketing [1] - The approval is significant for clinical applications in local anesthesia and postoperative pain management [1]